The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Effect of Prophylactic Human Papillomavirus (HPV) Vaccination on Oral HPV Infections Among Young Adults in the United States
Open accessAbstract
Purpose: The incidence of human papilloma virus (HPV)–positive oropharyngeal cancers has risen rapidly in recent decades among men in the United States. We investigated the US population–level effect of prophylactic HPV vaccination on the burden of oral HPV infection, the principal cause of HPV-positive oropharyngeal cancers. Methods: We conducted a cross-sectional study of men and women 18 to 33 years of age (N = 2,627) within the National Health and Nutrition Examination Survey 2011 to 2014, a representative sample of the US population. Oral HPV infection with vaccine types 16, 18, 6, or 11 was compared by HPV vaccination status, as measured by self-reported receipt of at least one dose of the HPV vaccine. Analyses accounted for the complex sampling design and were adjusted for age, sex, and race. Statistical significance was assessed using a quasi-score test. Results: Between 2011 and 2014, 18.3% of the US population 18 to 33 years of age reported receipt of at least one dose of the HPV vaccine before the age of 26 years (29.2% in women and 6.9% in men; P < .001). The prevalence of oral HPV16/18/6/11 infections was significantly reduced in vaccinated versus unvaccinated individuals (0.11% v 1.61%; P adj = .008), corresponding to an estimated 88.2% (95% CI, 5.7% to 98.5%) reduction in prevalence after model adjustment for age, sex, and race. Notably, the prevalence of oral HPV16/18/6/11 infections was significantly reduced in vaccinated versus unvaccinated men (0.0% v 2.13%; P adj = .007). Accounting for vaccine uptake, the population-level effect of HPV vaccination on the burden of oral HPV16/18/6/11 infections was 17.0% overall, 25.0% in women, and 6.9% in men. Conclusion: HPV vaccination was associated with reduction in vaccine-type oral HPV prevalence among young US adults. However, because of low vaccine uptake, the population-level effect was modest overall and particularly low in men.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
Chaturvedi, A. K., Engels, E. A., Pfeiffer, R. M., Hernandez, B. Y., Xiao, W., Kim, E., Jiang, B., Goodman, M. T., Sibug-Saber, M., Cozen, W., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.4596 · Cited by 3,638
Self-citationEpidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma
Gillison, M. L., Chaturvedi, A. K., Anderson, W. F., & Fakhry, C. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.6995 · Cited by 1,219
Self-citationPrevalence of Oral HPV Infection in the United States, 2009-2010
Gillison, M. L., Broutian, T., Pickard, R. K. L., Tong, Z.-Y., Xiao, W., Kahle, L., Graubard, B. I., & Chaturvedi, A. K. (2012) · JAMA · doi:10.1001/jama.2012.101 · Cited by 1,064
Self-citationPetrosky, E. Y., Bocchini, J. A., Hariri, S., Chesson, H. W., Curtis, C. R., Saraiya, M., Unger, E. R., & Markowitz, L. E. (2015) · PubMed · Cited by 1,047
US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines
Saraiya, M., Unger, E. R., Thompson, T. D., Lynch, C. F., Hernandez, B. Y., Lyu, C. W., Steinau, M., Watson, M., Wilkinson, E. J., Hopenhayn, C., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv086 · Cited by 761
Markowitz, L. E., Hariri, S., Lin, C., Dunne, E. F., Steinau, M., McQuillan, G., & Unger, E. R. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit192 · Cited by 521
Herrero, R., Quint, W., Hildesheim, A., Gonzalez, P., Struijk, L., Katki, H. A., Porras, C., Schiffman, M., Rodriguez, A. C., Solomon, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068329 · Cited by 473
Prevalence of HPV After Introduction of the Vaccination Program in the United States
Markowitz, L. E., Liu, G., Hariri, S., Steinau, M., Dunne, E. F., & Unger, E. R. (2016) · Pediatrics · doi:10.1542/peds.2015-1968 · Cited by 383
Reagan-Steiner, S., Yankey, D., Jeyarajah, J., Elam-Evans, L. D., Curtis, C. R., MacNeil, J., Markowitz, L. E., & Singleton, J. A. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6533a4 · Cited by 326
Propensity Score Analysis with Survey Weighted Data
Ridgeway, G., Kovalchik, S. A., Griffin, B. A., & Kabeto, M. U. (2015) · Journal of Causal Inference · doi:10.1515/jci-2014-0039 · Cited by 222
Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection
Beachler, D. C., Kreimer, A. R., SCHIFFMAN, M. H., Herrero, R., Wacholder, S., Rodríguez, A. C., Lowy, D. R., Porras, C., Schiller, J. T., Quint, W. G. V., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv302 · Cited by 126
Dorell, C., Jain, N., & Yankey, D. (2011) · Public Health Reports · doi:10.1177/00333549111260s208 · Cited by 94
Prevalence of oral human papillomavirus by vaccination status among young adults (18–30 years old)
Hirth, J. M., Chang, M., Resto, V. A., Guo, F., & Berenson, A. B. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.05.025 · Cited by 91
Lowy, D. R., Herrero, R., & Hildesheim, A. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70075-6 · Cited by 85
Testing logistic regression coefficients with clustered data and few positive outcomes
Hunsberger, S., Graubard, B. I., & Korn, E. L. (2007) · Statistics in Medicine · doi:10.1002/sim.3011 · Cited by 8
Self-citation
Cited by
Head and neck squamous cell carcinoma
Johnson, D. E., Burtness, B., Leemans, C. R., Lui, V. W. Y., Bauman, J. E., & Grandis, J. R. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00224-3 · Cited by 4,067
Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070
Soerjomataram, I., & Bray, F. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00514-z · Cited by 1,012
HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management
Lechner, M., Liu, J., Masterson, L., & Fenton, T. R. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00603-7 · Cited by 979
Oral squamous cell carcinomas: state of the field and emerging directions
Tan, Y., Wang, Z., Xu, M., Li, B., Huang, Z., Qin, S., Nice, E. C., Tang, J., & Huang, C. (2023) · International Journal of Oral Science · doi:10.1038/s41368-023-00249-w · Cited by 831
The changing therapeutic landscape of head and neck cancer
Cramer, J. D., Burtness, B., Le, Q. T., & Ferris, R. L. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0227-z · Cited by 783
Metadata
- Authors
- Chaturvedi, A. K., Graubard, B. I., Broutian, T., Pickard, R. K. L., Tong, Z.-Y., Xiao, W., Kahle, L., & Gillison, M. L.
- Venue
- Journal of Clinical Oncology
- Published
- 2018-01-20
- Volume
- 36
- Issue
- 3
- Pages
- 262-267
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2769890966
- Cited by
- 320
- References
- 16
- FWCI
- 19.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.